⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1269711 | 0.81 | — | — | |
| SCHEMBL5929267 | 0.74 | GLA (0.33) | — | |
| SCHEMBL1541732 | 0.65 | MGLL (0.33) | — | |
| SCHEMBL863100 | 0.65 | MGLL (0.33) | — | |
| SCHEMBL18020563 | 0.64 | SLC1A2 (0.45) | — | |
| SCHEMBL3468975 | 0.64 | MEN1 (0.30) | — | |
| SCHEMBL11588858 | 0.63 | PIK3CD (0.31) | — | |
| SCHEMBL43849 | 0.61 | SLC1A2 (0.40) | — | |
| SCHEMBL7019667 | 0.60 | — | — | |
| SCHEMBL93292 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010078376-A2 | FC-SPECIFIC POLYMER-CONJUGATED ANTIBODIES AND THEIR DIAGNOSTIC USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2010-07-08 | — | — | WO | claimed |
| EP-0382781-B1 | COMPOSITION FOR TREATING CANCERS CHARACTERIZED BY OVER-EXPRESSION OF THE C-FMS PROTO-ONCOGENE | GENETICS INSTITUTE, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| US-20260109728-A1 | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | TALLAC THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12351598-B2 | Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use | Tallac Therapeutics, Inc. (US) | 2025-07-08 | — | — | US | disclosed |
| US-12280021-B2 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2025-04-22 | — | — | US | disclosed |
| EP-4257186-B1 | AFFINITY MEDICANT CONJUGATES | AF CHEMICALS LLC (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20230372267-A1 | AFFINITY MEDICANT CONJUGATE | Califia Pharma Inc. (US) | 2023-11-23 | — | — | US | disclosed |
| EP-4257186-A2 | AFFINITY MEDICANT CONJUGATES | AF Chemicals LLC (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-3129357-B1 | AFFINITY MEDICANT CONJUGATES | AF CHEMICALS LLC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11359185-B2 | Antibody conjugates | VENTANA MEDICAL SYSTEMS, INC. (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220056069-A1 | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | HORIZON TECHNOLOGY FINANCE CORPORATION | 2022-02-24 | — | — | US | disclosed |
| WO-2002082078-A2 | ACTIVATED ENZYME-LINKED DETECTION SYSTEMS FOR DETECTING AND QUANTIFYING NUCLEID ACIDS, ANTIGENS ANTIBODIES AND OTHER ANALYTES | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2002-10-17 | — | — | WO | disclosed |
| WO-2002081739-A2 | NON-ENZYMATIC LIPOSOME-LINKED CLOSELY SPACED ARRAY ELECTRODES ASSAY (NEL-ELA) FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-10-17 | — | — | WO | disclosed |
| WO-2002081738-A2 | SYSTEM AND METHOD FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS USING COVALENT BINDING | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2002-10-17 | — | — | WO | disclosed |
| US-20020048598-A1 | INTERNALLY SUPPORTED LIPID VESICLE SYSTEMS | MALIK NAVID (GB) | 2002-04-25 | — | — | US | disclosed |
| US-20020006623-A1 | Compositions and methods for array-based genomic nucleic acid analysis of biological molecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-01-17 | — | — | US | disclosed |
| WO-2001041827-A1 | INTERNALLY SUPPORTED BIOMIMETIC MATERIALS AND COATINGS | MALIK NAVID (GB) | 2001-06-14 | — | — | WO | disclosed |
| EP-0998267-A1 | INTERNALLY SUPPORTED LIPID VESICLE SYSTEMS | Malik, Navid (GB) | 2000-05-10 | — | — | EP | disclosed |
| WO-1998056353-A1 | INTERNALLY SUPPORTED LIPID VESICLE SYSTEMS | MALIK NAVID (GB) | 1998-12-17 | — | — | WO | disclosed |
| EP-0382781-B1 | COMPOSITION FOR TREATING CANCERS CHARACTERIZED BY OVER-EXPRESSION OF THE C-FMS PROTO-ONCOGENE | GENETICS INSTITUTE, INC. (US) | 1993-09-29 | — | — | EP | disclosed |